Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 134,697 | 155,464 | 193,389 | 156,172 | 126,880 |
| Marketable Securities | 241,289 | 294,420 | 317,655 | 303,479 | 376,867 |
| Receivables | 9,131 | 9,468 | 11,050 | 11,353 | 10,504 |
| TOTAL | $466,449 | $527,711 | $581,941 | $495,945 | $551,392 |
| Non-Current Assets | |||||
| PPE Net | 15,516 | 17,671 | 20,421 | 22,806 | 25,123 |
| Investments And Advances | 179,271 | 190,790 | 158,814 | 170,855 | 203,353 |
| Other Non-Current Assets | 97,543 | 105,955 | 164,099 | 209,288 | 206,295 |
| TOTAL | $292,330 | $314,416 | $343,334 | $402,949 | $434,771 |
| Total Assets | $758,779 | $842,127 | $925,275 | $898,894 | $986,163 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,800 | 20,252 | 13,260 | 9,802 | 12,364 |
| Accrued Expenses | 37,920 | 49,862 | 40,841 | 41,553 | 40,805 |
| TOTAL | $76,445 | $103,884 | $93,726 | $95,499 | $112,593 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 630 | 7,290 | 12,247 | 17,154 | 20,661 |
| Other Non-Current Liabilities | 61,395 | 66,849 | 70,588 | 75,601 | 80,490 |
| TOTAL | $61,395 | $66,849 | $83,127 | $88,140 | $93,651 |
| Total Liabilities | $137,840 | $170,733 | $176,853 | $183,639 | $206,244 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,722 | 118,134 | 115,830 | 107,347 | 103,583 |
| Common Shares | 12 | 12 | 12 | 10 | 10 |
| Retained earnings | -2,686,325 | -2,590,094 | -2,494,308 | -2,392,984 | -2,291,729 |
| Other shareholders' equity | -240 | 1,032 | 990 | 653 | 1,057 |
| TOTAL | $620,939 | $671,394 | $748,422 | $715,255 | $779,919 |
| Total Liabilities And Equity | $758,779 | $842,127 | $925,275 | $898,894 | $986,163 |